Johansen, Pierre
Novo Nordisk (Denmark)
2 papers on CoChatORCID 0000-0002-6287-7508
Most cited papers
- Verified
Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK
Viljoen, A., Hoxer, C. S., Johansen, P., Malkin, S., Hunt, B., & Bain, S. C. (2019) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 45
- Verified
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States
Wilkinson, L., Hunt, B., Johansen, P., Iyer, N. N., Dang-Tan, T., & Pollock, R. F. (2018) · Diabetes Therapy
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free